Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate

Asian Journal of Andrology

Volumn 9, Issue 2, 2007, Pages 229-233

  Stamatiou, Konstantinos ^a,b   Alevizos, Alevizos ^a,b,c   Natzar, Mohamed ^b   Mihas, Constantinos ^c   Mariolis, Anargiros ^c   Michalodimitrakis, Emmanouel ^a   Sofras, Fragiskos ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c Health Center of Vyronas   (Greece)

Author keywords

Atypical adenomatous hyperplasia; Benign prostate hypertrophy; Histological prostate cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOPSY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ORGAN SIZE; PROSTATE ADENOMA; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 33947254588     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2007.00187.x     Document Type: Article

References (29)

1. Gleason DF. Atypical hyperplasia, benign hyperplasia and well differentiated adenocarcinoma of the prostate. Am J Surg Pathol 1985; 9: 53-67.
2. Totten RS, Heinemann MW, Hudson PB, Sproul EE, Stout AP. Microscopic differential diagnosis of latent carcinoma of the PIN low-grade prostate adenocarcinoma and adenosis. Hum Pathol 1953; 24: 618-23.
3. Soos G, Tsakiris I, Szanto J, Turzo C, Haas PG, Dezso B. The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study. Eur Urol 2005; 48: 739-44.
4. Lundberg S, Berge T. Prostatic carcinoma An autopsy study. Scand J Urol Nephrol 1970; 4: 93-7.
5. Harbitz TB, Haugen OA. Histology of the prostate in elderly men A study in an autopsy series. Acta Pathol Microbiol Scand [A] 1972; 80: 756-68.
6. Billis, A. Latent carcinoma and atypical lesions of prostate An autopsy study. Urology 1986; 28: 324-9.
7. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9.
8. Sesterhenn IA. Prostate and testis tumor AFIP Genitourinary pathology: WHO classification of tumors pathology and genetics of the tumors of the urinary system and male genital organs. Washington: World Health Organization, 2003.
9. McNeal JE, Gleason DF. Gleason's classification of prostatic adenocarcinomas. Ann Pathol 1991; 11: 163-8.
10. Bostwick GD. Pathology of the prostate. New York: Churchill Livingstone, 1990.
11. Montironi R, Mazzucchelli R, Kwast T. Morphological assessment of radical prostatectomy specimens A protocol with clinical relevance. Virchows Arch 2003; 442: 211-7.
12. Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey, P, van der Kwast, TH, et al. Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993; 24: 818-32.
13. Grignon DJ, Sakr WA. Atypical adenomatous hyperplasia of prostate: A critical review. Eur Urol 1996; 30: 206-11.
14. Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 1995; 19: 506-18.
15. Foster CS, Sakr W. Exclusion of Prostate Cancer by Pathological Assessment of Prostatic Biopsy Specimens. In:
16. Chatelain C, Denis L, Foo K, Khoury S, McConnel, J, editors. Benign Prostatic Hyperplasia. Plymouth: Plumdridge (distributors), 2000. p 294-305.
17. McNeal JE. Morphogenesis of prostatic carcinoma. Cancer 1965; 18: 1659-66.
18. Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Atypical adenomatous hyperplasia of the prostate: A premalignant lesion? Cancer Res 1998, 58: 389-91.
19. Brawn PN. Adenosis of the prostate: A dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 1982; 49: 826-33.
20. Kastendieck H. Correlations between atypical primary hyperplasia and carcinoma of the prostate. Pathol Res Pract 1980: 169; 366-87.
21. Hoffman L, Putzke HP, Gunther I, Rodewald P, Erdmann T. Relations between atypical hyperplasia and latent carcinoma of the prostate. Z Urol Nephrol 1987: 80; 561-9.
22. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992; 70: 291-301.
23. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread. Hum Pathol 1992; 23: 258-66.
24. Bostwick DG. Prospective origins of prostate carcinoma Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996; 78: 330-6.
25. Hoda SA, Reed RJ. Morphologic characteristics of nucleoli in the differential diagnosis of well-differentiated prostatic adenocarcinoma. Am J Clin Pathol 1991, 95: 271 [abstract].
26. Lopez-Bettran A, Pacelli A, Qian J, Jenkins RB, Bortmelz DG. Atypical adenomatous hyperplasia of the prostate: Immunophenotype, genotype and DNA ploidy analysis. Mod Pathol 1996; 9: 77A [abstract].
27. Humphrey PA, Zhu X, Crouch EC, Carbone JM, Keetch DW. Mass-formative atypical adenomatous hyperplasia of prostate. J Urol Pathol 1998; 9: 73-81.
28. Qian J, Jenkins RB, Bostwick DG. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Urology 1995; 46: 837-42.
29. Epstein JI. Adenosis (atypical adenomatous hyperplasia): Histopathology and relationship to carcinoma. Pathol Res Pract 1995; 191: 888-98.